Enhertu | Trastuzumab Deruxtecan Injection

✓ Revolutionary HER2-directed antibody-drug conjugate (ADC)

✓ High drug-to-antibody ratio with potent topoisomerase I payload

✓ Unmatched efficacy in HER2-positive & HER2-low breast cancers

✓ Powerful bystander tumor cell killing effect

✓ Breakthrough HER2 oncology therapy

Guaranteed Safe Checkout

Onlinemedex Features:-

Fulfilled-using-ems

Generic Name :	Trastuzumab Deruxtecan
Drug class:	HER2 Antibody-Drug Conjugate (ADC)
CSA Schedule:	Non-controlled drug
Approval:	FDA approved 2019

Reviews

There are no reviews yet.

Be the first to review “Enhertu | Trastuzumab Deruxtecan Injection”